Last update 01 Nov 2024
Arrow Pharmaceuticals Pty Ltd.
Last update 01 Nov 2024
Overview
Tags
Otorhinolaryngologic Diseases
Digestive System Disorders
Mouth and Tooth Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
A multicenter, open label, randomized, balanced, two treatment, three period, three sequence, reference replicate crossover, single dose, bioequivalence study of Capecitabine Tablets, USP 500mg manufactured by Amneal Pharmaceuticals, USA and XELODA® (Capecitabine) Tablets 500mg distributed by Genentech USA, Inc., A Member of the Roche Group, 1 DNA Way, South San Francisco, CA 94080-4990, following a single oral 2000mg (4x500mg) dose administration in adult human cancer patients under fed condition.
100 Clinical Results associated with Arrow Pharmaceuticals Pty Ltd.
Login to view more data
Login to view more data
03 May 2022Neurology
A Phase 3 Trial of IPX203 vs CD-LD IR in Parkinson’s Disease Patients with Motor Fluctuations (RISE-PD) (S16.010)
Author: LeWitt, Peter ; Stocchi, Fabrizio ; Ellenbogen, Aaron ; Espay, Alberto J. ; Isaacson, Stuart ; Hauser, Robert A. ; Pahwa, Rajesh ; D’Souza, Richard ; Visser, Hester
03 May 2022Neurology
Duration of Benefit Per Dose: Post Hoc Analysis of “Good On” Time Per Dose for IPX203 vs CD-LD IR in the RISE-PD Phase 3 Trial (P10-11.002)
Author: Fisher, Stanley ; Fernandez, Hubert H. ; Banisadr, Ghazal ; Patel, Neepa ; Criswell, Susan ; Klos, Kevin ; Hauser, Robert A.
100 Deals associated with Arrow Pharmaceuticals Pty Ltd.
Login to view more data
100 Translational Medicine associated with Arrow Pharmaceuticals Pty Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 15 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free